Health

Pfizer Submits Favorable Initial Data To The FDA On Kids' COVID-19 Vaccine Trial

By Bill Chappell
Published September 28, 2021 at 7:54 AM CDT
  • Twitter
  • LinkedIn
  • Email
HealthhealthCOVID-19coronavirus vaccinePfizer
  • Twitter
  • LinkedIn
  • Email
Bill Chappell
Bill Chappell is a writer and editor on the News Desk in the heart of NPR's newsroom in Washington, D.C.
See stories by Bill Chappell
Related Content
  1. An FDA Panel Says Only High-Risk Americans And Those 65+ Should Get COVID Boosters
  2. COVID Vaccine For Kids Ages 5 To 11 Is Safe And Effective, Pfizer Says
  3. Secretary for Health and Human Services Urging Kentuckians To Get Vaccinated Against COVID-19
  4. Booster Shots Are Coming. Here's How To Figure Out If You Need One
  5. Rural Hospitals Worry They Will Lose Staff Because Of Biden's New Vaccine Mandate